Saturday, September 01, 2018 7:03:38 AM
Visa, Mastercard and other card companies are happy to license their brands, for a fee. And the banks that issue those cards are happy to collect their sponsor fees and the interest assessed on unpaid balances. Now the only question becomes who gets the back-office core responsibility, and reward, for being the middleman with the retail transaction world. The Old Dinosaurs? Or the New Wizards of Fin Tech?
Investors can certainly choose WP or FDC stock for their portfolio. Huge market cap. Huge outstanding shares. Some future growth from conservative and broadly-focused platforms like Zelle and Clover. They will get their share of the future and largely cashless payment landscape. Or...
Investors can choose PYPL, SQ or IIIV and the Fin Tech revolution that is reshaping payment processing to better suit the needs of the USER base. Not "one-size-fits-all" old school processing for the masses at a high fee basis. Nope. Narrow, targeted, niche-focused specialty platforms that align custom programs with custom software and custom features that actually serve the needs of the Millenial user base that wants no bank account, wants no card fees and carries no cash with them.
Easy choice for me. I am very long SQ and getting there with IIIV. PYPL is too large, now, to experience the post-IPO surge that is now happening at SQ and will begin to kick in with IIIV in mid-to-late 2019.
GLTA.
Recent IIIV News
- i3 Verticals Announces Earnings Release and Conference Call Date for Second Quarter of Fiscal 2024 • Business Wire • 05/03/2024 07:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:02:42 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/14/2024 09:56:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:43:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:42:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:41:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:41:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:40:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:39:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:39:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:39:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:38:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:37:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:36:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:35:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2024 09:03:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:07:01 PM
- i3 Verticals Reports First Quarter 2024 Financial Results • Business Wire • 02/08/2024 09:05:00 PM
- i3 Verticals Announces Earnings Release and Conference Call Dates for First Quarter of Fiscal 2024 • Business Wire • 01/25/2024 04:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 01/09/2024 09:17:09 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/09/2024 09:15:21 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/09/2024 09:12:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 02:01:37 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/22/2023 10:07:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:26:57 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM